Smart Money Group’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
Smart Money Group's IBB Position: Q2 2022 in Review
Smart Money Group sold out of iShares Biotechnology ETF (IBB) in Q2 2022, closing a stake of 9,623 shares — an estimated $1.25M sold.
Smart Money Group first reported a position in IBB in Q3 2021 and held it in 3 quarters. The position peaked at $2.35M in Q4 2021. 858 funds tracked by Wall St. Rank hold IBB as of Q2 2022.
- Smart Money Group reported no remaining iShares Biotechnology ETF position as of Q2 2022 after selling out during the quarter.
- Smart Money Group sold 9,623 iShares Biotechnology ETF shares in Q2 2022, an estimated $1.25M.
- Smart Money Group first reported a position in iShares Biotechnology ETF in Q3 2021 and held it in 3 quarters.
- Smart Money Group's iShares Biotechnology ETF position peaked at $2.35M in Q4 2021.
- 858 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2022.
Based on Smart Money Group's 13F filing for Q2 2022, filed 14 Jul 2022.